Scilex Holding Company
Organization details
- Legal name
- Scilex Holding Company
- Former names
- Vickers Vantage Corp. I
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Palo Alto
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SCLX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001820190
Board of directors
-
Annu Navani · DirectorSince 2024
-
David Lemus · DirectorSince 2023
-
Dorman Followwill · DirectorSince 2023
-
Henry Ji · Director · Exec Chair, CEO and PresidentSince 2023
-
Jaisim Shah · Director · See RemarksSince 2023
-
Jay Chun · DirectorSince 2023
-
Laura Hamill · DirectorSince 2023
-
Stephen Hoi Ma · Director · CFO, COO and SecretarySince 2025
-
Tien-Li Lee · DirectorSince 2023
-
Tommy G. Thompson · DirectorSince 2023
-
Yue Alexander Wu · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.6%
Board connections
4 of this board's directors also sit on 8 other boards. 7 are in the same sector.
-
Aardvark Therapeutics Inc. Same sectorvia Tien-Li Lee
-
AnaptysBio Inc. Same sectorvia Laura Hamill
-
Fate Therapeutics Inc. Same sectorvia Laura Hamill
- via Tommy G. Thompson
-
Jazz Pharmaceuticals plc Same sectorvia Laura Hamill
- via David Lemus
-
TherapeuticsMD Inc. Same sectorvia Tommy G. Thompson
-
United Therapeutics Corporation Same sectorvia Tommy G. Thompson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $12,806,953
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 3, 2026 | SCLX Stock Acquisition JV LLC 10% owner | Other | −500,000 | — | — |
| Dec 30, 2025 | Scilex Holding Co 10% owner | Open-market sale | −9,657,300 | $0.54 | $5,214,942 |
| Dec 29, 2025 | Scilex Holding Co 10% owner | Open-market sale | −7,310,984 | $0.66 | $4,825,249 |
| Dec 26, 2025 | Scilex Holding Co 10% owner | Open-market sale | −3,689,016 | $0.75 | $2,766,762 |
| Jan 21, 2025 | SCLX Stock Acquisition JV LLC 10% owner | Other | −3,250,000 | — | — |
| Jan 16, 2025 | SCLX Stock Acquisition JV LLC 10% owner | Other | −779,371 | — | — |
| Jan 2, 2025 | SCLX Stock Acquisition JV LLC 10% owner | Other | −5,000,000 | — | — |
| Dec 18, 2024 | Jaisim Shah Director, Officer (See Remarks) | Open-market purchase | +30,000 | $0.46 | $13,800 |
| Oct 31, 2024 | Henry Ji Director, Officer (Executive Chairperson) | Open-market purchase | +8,888 | $0.94 | $8,355 |
| Oct 29, 2024 | Jaisim Shah Director, Officer (See Remarks) | Open-market purchase | +32,000 | $0.99 | $31,680 |
| Oct 18, 2024 | Dorman Followwill Director | Open-market purchase | +1,000 | $0.99 | $990 |
| Oct 18, 2024 | Jay Chun Director | Open-market purchase | +5,000 | $0.95 | $4,750 |
| Oct 17, 2024 | Yue Alexander Wu Director | Open-market purchase | +20,000 | $0.95 | $19,000 |
| Oct 17, 2024 | David Lemus Director | Open-market purchase | +2,000 | $0.90 | $1,800 |
| Oct 17, 2024 | Henry Ji Director, Officer (Executive Chairperson) | Open-market purchase | +10,000 | $0.97 | $9,700 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Scilex Holding Company
Who is the CEO of Scilex Holding Company?
Henry Ji is Scilex Holding Company's CEO and President.
How many directors are on Scilex Holding Company's board?
Scilex Holding Company's board has 11 directors: Annu Navani, David Lemus, Dorman Followwill, Henry Ji, Jaisim Shah, Jay Chun, Laura Hamill, Stephen Hoi Ma, Tien-Li Lee, Tommy G. Thompson and 1 other.
Are Scilex Holding Company insiders buying or selling shares?
Over the last 12 months, Scilex Holding Company insiders made no open-market purchases and sold $12.8 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="scilex-holding-company"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.